Publications

Scientific Work & Research Output

A comprehensive showcase of our published research, including journal articles, books and book chapters. Explore our scientific contributions and their impact.

Search Publications

Published Works

2025

PARAFAC under non-negativity constraint is adapted to recover the underlying Beer-Lambert law of the excitation-emission fluorescence matrix measurements acquired from analyte-triggered semiconductor QDs photoluminescence modulation. When and why?

Mazivila, Sarmento J.; Soares, José X.; Lapa, Rui A.S.; Saraiva, M. Lúcia M.F.S.; Fernandes, José O.; Cunha, Sara C.; Santos, Joao L.M.

Journal Talanta
View publication

Beer-Lambert law Cation bridging Chemical rank EEFM measurements Fluorescence quenching Ligand-driven sensing

Phosphodiesterase 3 inhibition mitigates sepsis progression in a rodent sepsis model

Oliveira, Junior Garcia; Ferreira Alves, Gustavo; Anton, Elaine Leocádia; Souza-Silva, Eduardo; da Silva-Santos, José Eduardo; Zimath, Priscila Laiz; Delfrate, Gabrielle; Falchetti, Marcelo; Machado, Natã; Vojtek, Martin; Oliveira, Marcia Regina Paes; Dias-Pereira, Patrícia; Sordi, Regina; Diniz, Carmen; Fernandes, Daniel

Journal Life Sciences
View publication

Cyclic nucleotides Cilostazol Cardiovascular system Septic shock Cecal ligation and puncture

Post-marketing surveillance of upadacitinib: multilevel analysis of venous thromboembolism reporting in global data and rheumatoid arthritis

Renato Ferreira-da-Silva; Mariana Lobo; Ana Rafaela Abreu; Juliana Pereira-Macedo; Beatriz Mós; Carolina Ameijeiras Rodriguez; Inês Mariana Lourenço; Isabel Vieira; Jorge Junqueira Polónia; Luís Gouveia; Lurdes Silva; Morato, Manuela; Manuela Pinto; Mario Forrester; Marta Pereira; Nuno Rodrigues; Tayanny Biase; Inês Ribeiro.

Journal Frontiers in Medicine
View publication

Janus kinase inhibitors venous thromboembolism pharmacovigilance drug-related side effects and adverse reactions rheumatoid arthritis adverse drug reaction reporting systems

Post-marketing surveillance study on the effectiveness and safety of molnupiravir in high-risk COVID-19 outpatients: a prospective case series study

Ferreira-da-Silva, Renato; Silva, Lurdes, Costa-Santos, Cristina, Morato, Manuela, Polónia, Jorge Junqueira; Ribeiro-Vaz, Inês; Pinto, Manuela; Pereira, Marta; Figueira, Inês Marques; Baptista, Sofia; Farinha, Helena; Falcão, Fátima; Mirco, Ana; Calixto, Liliana; Melo, Madalena; ESOA-19 Research Team

Journal Pharmacological Reports
View publication

SARS-CoV-2 COVID-19 drug treatment Antiviral agents Molnupiravir Post-marketing surveillance Adverse drug events